Lobko, Igor MD

North American Partners in Anesthesia (NAPA) is the largest single-specialty clinician-led anesthesia organization in the United States, boasting 35 years of seasoned experience and serving over 2 million patients annually across 23 states. Renowned for their innovative solutions, NAPA focuses on enhancing patient safety, satisfaction, and operational efficiency through quality care and robust analytics. Committed to fostering a collaborative community, NAPA emphasizes surgeon satisfaction and clinician focus while promoting professional development and work-life balance. Their national infrastructure supports local perioperative leadership, effectively driving clinical excellence and meeting the evolving demands of healthcare systems. Generated from the website

Lawrence C. Wolfe, MD, situated in New Hyde Park, NY, is a renowned medical practice known for its dedication to providing top-tier healthcare services to its patients. Specializing in a variety of medical treatments, they offer a range of services from primary care to advanced surgical interventions, ensuring comprehensive medical care for individuals in need. Their team of skilled professionals is actively engaged in medical research, education, and community health programs, striving to enhance patient care and healthcare outcomes for all. At Lawrence C. Wolfe, MD, the focus extends beyond treatment to include a commitment to fostering innovation and improving wellness in the local community. Through ongoing involvement in clinical trials, development of cutting-edge technologies, and fostering meaningful partnerships, they aim to advance healthcare standards and promote overall well-being among the population they serve. With a strong emphasis on quality healthcare delivery and a proactive approach to healthcare development, Lawrence C. Wolfe, MD, stands as a beacon of excellence in the medical field. Generated using this brand's available information

I am a pediatric hematologist/oncologist who specializes in stem cell transplantation and cellular therapy. I graduated from the Upstate Medical University, completed a residency in pediatrics at the Schneider Children's Hospital, served as Chief Resident of Pediatrics at the Schneider Children's Hospital, and then completed my training with a fellowship in pediatric hematology / oncology at the Children s Hospital of Philadelphia. During my fellowship, I concurrently spent 3 years in the laboratory researching cellular immunotherapy for acute lymphoblastic leukemia, while also pursuing a clinical interest in the late effects of childhood cancer treatment. In 2008 I came to the Cohen Children s Medical Center to found Survivors Facing Forward, a long-term follow-up program to provide care to survivors of childhood cancer and stem cell transplantation. Since 2008, the program has grown to follow nearly 1,000 survivors of childhood cancer and has been a fertile source for clinical research. In 2021 I assumed leadership of the stem cell transplantation and cellular therapy program at Cohen Children's Medical Center, where I am the Transplant Center Medial Director and Marrow Collection Facility Director. Our transplant center participates in national and international cooperative group studies in the use of stem cell transplantation and cellular therapy to treat cancers, bone marrow failure syndromes, immune deficiencies and hemoglobinopathies (sickle cell disease and thalassemia). Notably, we are one of a very limited number of Qualified Treatment Centers (QTC) for Zynteglo , an FDA approved gene therapy for transfusion dependent thalassemia, and are in the process of being named a QTC for gene therapy products recently FDA approved to cure sickle cell disease.